β¨ Medicine and Toxic Substances Notices
13 AUGUST
NEW ZEALAND GAZETTE
2769
Classification of Medicines
Pursuant to section 106 (1) of the Medicines Act 1981, the Minister of Health, hereby declares the medicines listed in Schedules one, two, three and four to this notice to have the classifications Prescription Medicine, Restricted Medicine, Pharmacy-Only Medicine and General Sale Medicine respectively.
First Schedule
Prescription Medicines
Altretamine.
Amifostine.
Clozapine.
Fleroxacin.
Fludarabine; and its salts.
Foscavir.
Glutathione; for parenteral use.
Levamisole; and its salts.
Lignocaine; and its salts; in medicines for parenteral use; and for internal use by ingestion other than throat lozenges; and for use in the eye except when used by a registered optometrist in his practice as an optometrist.
Nebacumab.
Nimodipine.
Proxymetacaine; and its salts; except when used by a registered optometrist in his practice as an optometrist.
Torasemide.
Zalcitabine.
Second Schedule
Restricted Medicines
Cholestyramine resin.
Ether; except when used as a vehicle for a topical dose form.
Hydrocortisone; and hydrocortisone acetate; in dermatological medicines containing 1% or less and more than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container.
Natamycin; for buccal use; and for vaginal use when in pack sizes equivalent to one course of treatment.
Nicotinamide: in medicines containing more than 100mg per dose form.
Nicotinic acid: in medicines containing more than 100mg per dose form.
Nicotinyl alcohol: in medicines containing more than 100mg per dose form.
Quinine; and its salts; in medicines containing 200mg or less per dose form and in packs containing not more than 5 daysβ supply for the treatment of cramp.
Third Schedule
Pharmacy-Only Medicines
Calcium glucono-galacto-gluconate; for parenteral use.
Cetirizine; and its salts.
Desoxyribonuclease; for external use.
Ether; when used as a vehicle for a topical dose form.
Hydrocortisone; and hydrocortisone acetate; in dermatological medicines containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container.
Lignocaine; and its salts; in medicines for external use containing more than 2% of lignocaine.
Naproxen; and its salts; in solid dose forms containing the equivalent of 250 milligrams of naproxen per dose form, when in a pack containing not more than 20 tablets or capsules and sold for the treatment of dysmenorrhoea.
Oxiconazole nitrate;
Oxymetazoline; and its salts; for nasal use except when sold at an airport.
Phenylephrine; and its salts; for nasal use except when sold at an airport.
Xylometazoline; and its salts; except for nasal use when sold at an airport.
Fourth Schedule
General Sale Medicines
Berberine.
Calcium glucono-galacto-gluconate; except for parenteral use.
Choline Salicylate.
Lignocaine; and its salts; in medicines for external use containing 2% or less of lignocaine.
Nicotinamide: in medicines containing 100mg or less per dose form.
Nicotinic acid: in medicines containing 100mg or less per dose form.
Nicotinyl alcohol: in medicines containing 100mg or less per dose form.
Oxymetazoline; and its salts; for nasal use when sold at an airport.
Phenylephrine; and its salts; in eye preparations containing 0.12% or less of phenylephrine; and for nasal use when sold at an airport.
Xylometazoline; and its salts, for nasal use when sold at an airport.
Dated this 26th day of June 1992.
MAURICE WILLIAMSON, Associate Minister of Health.
go7252
Toxic Substances Act 1979
The Toxic Substances (Captafol Prohibition) Notice 1992
Pursuant to section 33 of the Toxic Substances Act 1979, the Minister of Health hereby gives the following notice.
-
This notice may be cited as the Toxic Substances Captafol Prohibition Notice 1992.
-
The Minister of Health hereby gives notice that on the recommendations of both the Toxic Substances Board and the Pesticides Board the sale, possession and use of captafol is prohibited except:
(1) In formulations which are pruning pastes; and
(2) as an active ingredient for incorporation into pruning pastes.
- This notice shall remain in force for the period of 12 months after it appears in the Gazette.
Dated at Wellington this 30th day of July 1992.
SIMON UPTON, Minister of Health.
go7251
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1992, No 127
NZLII —
NZ Gazette 1992, No 127
β¨ LLM interpretation of page content
π₯ Classification of Medicines under the Medicines Act 1981
π₯ Health & Social Welfare26 June 1992
Medicines Act, Prescription Medicine, Restricted Medicine, Pharmacy-Only Medicine, General Sale Medicine, Altretamine, Clozapine, Fleroxacin, Fludarabine, Foscavir, Glutathione, Levamisole, Lignocaine, Nebacumab, Nimodipine, Proxymetacaine, Torasemide, Zalcitabine, Cholestyramine, Ether, Hydrocortisone, Natamycin, Nicotinamide, Nicotinic acid, Nicotinyl alcohol, Quinine, Calcium glucono-galacto-gluconate, Cetirizine, Desoxyribonuclease, Naproxen, Oxiconazole nitrate, Oxymetazoline, Phenylephrine, Xylometazoline, Berberine, Choline Salicylate
- MAURICE WILLIAMSON, Associate Minister of Health
π₯ Prohibition of Captafol under the Toxic Substances Act 1979
π₯ Health & Social Welfare30 July 1992
Toxic Substances Act, Captafol, Prohibition, Pruning pastes
- SIMON UPTON, Minister of Health